Association between polycystic ovary syndrome and pregnancy outcomes in GDM: A secondary analysis of the DiGest trial - Scorecard - MDSpire

Association between polycystic ovary syndrome and pregnancy outcomes in GDM: A secondary analysis of the DiGest trial

  • By

  • Laura C Kusinski

  • Zhaohui Liu

  • Sarah Dib

  • Rebecca Rogers

  • Amy E Morrison

  • Danielle L Jones

  • Claire L Meek

  • January 28, 2026

  • 0 min

Share

Clinical Scorecard: Link Between Polycystic Ovary Syndrome and Pregnancy Outcomes in Gestational Diabetes Mellitus: Insights from a Secondary Analysis of the DiGest Study

At a Glance

CategoryDetail
ConditionPolycystic Ovary Syndrome (PCOS) and Gestational Diabetes Mellitus (GDM)
Key MechanismsShared insulin resistance and adiposity contributing to metabolic complications
Target PopulationPregnant women with GDM and BMI ≥25 kg/m2
Care SettingMulticenter clinical trial settings in the UK, including antenatal care

Key Highlights

  • Women with GDM and PCOS had similar baseline characteristics, glycemia, BMI, and pregnancy outcomes compared to women with GDM alone.
  • Infants of women with PCOS had higher rates of neonatal jaundice (24.4% vs 8.9%, P = .002).
  • Dietary interventions (reduced-energy vs standard-energy diets) showed similar outcomes in women with and without PCOS.

Guideline-Based Recommendations

Diagnosis

  • Diagnose GDM using OGTT based on NICE criteria or RCOG interim COVID-19 criteria.
  • Identify PCOS by self-report using Rotterdam Criteria (presence of at least 2 of: oligo-amenorrhea, clinical/biochemical hyperandrogenism, polycystic ovaries).

Management

  • Implement dietary interventions with controlled energy intake (1200 kcal/day reduced-energy diet vs 2000 kcal/day standard-energy diet) from 29 weeks gestation until delivery.
  • Maintain balanced macronutrient composition: 40% carbohydrates, 25% protein, 35% fat, excluding added sugars and artificial additives.

Monitoring & Follow-up

  • Monitor maternal weight change and continuous glucose metrics during pregnancy.
  • Assess neonatal outcomes including birthweight and incidence of neonatal jaundice.

Risks

  • Recognize increased risk of neonatal jaundice in infants born to women with PCOS and GDM.
  • Consider that PCOS does not independently increase most suboptimal pregnancy outcomes when BMI and glycemia are comparable.

Patient & Prescribing Data

Pregnant women with GDM and BMI ≥25 kg/m2, including those with self-reported PCOS

Dietary energy restriction interventions are equally effective in women with and without PCOS in managing GDM outcomes.

Clinical Best Practices

  • Use a double-blind randomized controlled trial design when assessing dietary interventions in GDM.
  • Adjust for confounding factors such as BMI, maternal age, fertility treatment, baseline glycemia, and dietary adherence when evaluating pregnancy outcomes.
  • Provide preprepared balanced meals to ensure compliance with dietary interventions during pregnancy.

References

Original Source(s)

Related Content